Bhupendra Singh Selected Research

Butylated Hydroxyanisole (BHA)

5/2013	Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancer.
12/2012	Superoxide dismutase 3 is induced by antioxidants, inhibits oxidative DNA damage and is associated with inhibition of estrogen-induced breast cancer.
1/2012	Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer.
5/2009	Antioxidant butylated hydroxyanisole inhibits estrogen-induced breast carcinogenesis in female ACI rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bhupendra Singh Research Topics

Disease

15	Breast Neoplasms (Breast Cancer) 11/2020 - 10/2008
14	Neoplasms (Cancer) 11/2020 - 10/2008
13	Carcinogenesis 12/2017 - 10/2008
2	Chronic Disease (Chronic Diseases) 01/2019 - 01/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 01/2015
1	Tuberculosis (Tuberculoses) 07/2022
1	Latent Tuberculosis 07/2022
1	Primary Myelofibrosis (Myelosclerosis) 07/2022
1	Lymphoma (Lymphomas) 10/2020
1	Migraine Disorders (Migraine) 01/2019
1	Asthma (Bronchial Asthma) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Hyperplasia 01/2018
1	Alopecia (Baldness) 01/2018
1	Genomic Instability 01/2017
1	Adenocarcinoma 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Hemolysis 06/2014

Drug/Important Bio-Agent (IBA)

13	Estrogens (Estrogen)FDA Link 01/2016 - 10/2008
8	AntioxidantsIBA 12/2014 - 05/2009
6	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2014 - 07/2009
5	ResveratrolIBA 01/2016 - 02/2013
5	Estrogen ReceptorsIBA 01/2016 - 10/2008
4	Proteins (Proteins, Gene)FDA Link 01/2015 - 05/2013
4	Butylated Hydroxyanisole (BHA)IBA 05/2013 - 05/2009
4	Oxidants (Oxidizing Agents)IBA 01/2011 - 05/2009
3	MicroRNAs (MicroRNA)IBA 11/2020 - 05/2013
3	Phytoestrogens (Phytoestrogen)IBA 01/2016 - 08/2014
2	Mitochondrial DNA (mtDNA)IBA 01/2018 - 01/2017
2	EnzymesIBA 12/2014 - 05/2013
2	Transcription Factors (Transcription Factor)IBA 12/2014 - 05/2013
2	Superoxide DismutaseIBA 12/2012 - 10/2008
2	8-Hydroxy-2'-DeoxyguanosineIBA 12/2012 - 01/2012
2	Atrial Natriuretic Factor (ANF)IBA 01/2012 - 07/2009
1	Interferon-gamma (Interferon, gamma)IBA 07/2022
1	ruxolitinibIBA 07/2022
1	OligonucleotidesIBA 11/2020
1	locked nucleic acidIBA 11/2020
1	AntagomirsIBA 11/2020
1	Blood Proteins (Serum Proteins)IBA 10/2020
1	TabletsIBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	Matrix Metalloproteinase InhibitorsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	4- (E)- ((p- tolylimino)- methylbenzene- 1,2- diol)IBA 01/2016
1	Amino Acids FDA Link 01/2015
1	IceIBA 06/2014
1	Messenger RNA (mRNA)IBA 05/2013
1	A-Form DNA (A-DNA)IBA 05/2013
1	DNA Glycosylases (DNA Glycosylase)IBA 05/2013
1	8-hydroxyguanineIBA 05/2013
1	Beclin-1IBA 02/2013
1	quinone (benzoquinone)IBA 01/2012
1	Oxidoreductases (Dehydrogenase)IBA 01/2012
1	NAD (NADH)IBA 01/2012
1	Tamoxifen FDA LinkGeneric 01/2011
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2011
1	salicylhydroxamic acid (SHAM)IBA 01/2011
1	QuercetinIBA 09/2010
1	alpha-naphthoflavoneIBA 07/2009
1	Glutathione PeroxidaseIBA 10/2008

Therapy/Procedure

3	Aftercare (After-Treatment) 05/2013 - 01/2012
1	Therapeutics 11/2020
1	Chronotherapy 01/2019